Overview
Revez Corporation Ltd., based in Singapore, operates primarily within the technology sector, specializing in digital multimedia and Information and Communication Technology (ICT) solutions. The company's portfolio extensively covers innovative projects and services including customized technology solutions such as Virtual Reality (VR), Augmented Reality (AR), Artificial Intelligence (AI), and Internet of Things (IoT) applications, serving various industries like healthcare, education, and public sectors. Revez is known for its comprehensive approach in integrating creative content and advanced technology to enhance digital user experiences and engagement. Key projects underscore its focus on multimedia and technology-driven solutions, positioning Revez as a frontrunner in expanding digital transformation capabilities across its multi-industry clientele.
AI+ Ask Fintel’s AI assistant about Assurance Healthcare Limited.
Thinking about good questions…
Basic Stats
The share price of Assurance Healthcare Limited as of 2 September 2025 is $0.05 / share. The market cap (or net worth) of Assurance Healthcare Limited as of 4 September 2025 is $14.22 MM.
The Factor Analysis chart (below right) shows a view of Assurance Healthcare Limited from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 14.22 MM |
| EV | 12.65 MM |
| Shares Out. | 263.32 MM |
| Earnings Date | |
| EPS (TTM) | -0.00 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.61 |
| Beta | -2.29 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | -12.57 |
| Price/Book | 2.20 |
| Price/TBV | 7.52 |
| Book/Market | 0.45 |
| EBIT/EV | -0.11 |
| EBIT(3yr avg)/EV | -0.23 |
| ROA | -0.13 |
| ROE | -0.15 |
| ROIC | -0.17 |
| CROIC | -0.24 |
| OCROIC | -0.15 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 39.12 /100 |
| Profitability | 9.27 /100 |
| Quality Score | 9.85 /100 |
| Value Score | 8.07 /100 |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 4.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Assurance Healthcare Limited. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| No data available. | ||||
